Abstract. Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most frequent cause of progressive cognitive decline in the elderly population. To date, there is still no effective treatment for AD, requiring more underlying mechanisms. In the present study, we investigated the effects of A␤ 42 on the inhibitory synaptic transmission in the cultured hippocampal neurons, and explored the possible mechanism. The frequency, but not amplitude, of miniature inhibitory postsynaptic currents was significantly suppressed by A␤ 42 , indicating that A␤ 42 played its role in inhibitory transmitter release at the pre-synaptic sites. A␤ 42 had no effect on miniature excitatory post-synaptic currents, suggesting GABAergic synapses are more susceptible to A␤ 42 exposure. However, the number of GABAergic neurons or synapses was not influenced, suggesting the corresponding stage may be a preclinical one. The effect of A␤ 42 can be mimicked by PD98059 (an inhibitor of ERK1/2) and blocked by curcumin (an activator of MEK), which reveals A␤-involved influence is via the decreased phosphorylation of MAPK-ERK1/2. In addition, synaptophysin is confirmed to be a downstream protein of MAPK-ERK1/2 at the pre-synaptic site. At the same time, suppressed autophagy was observed after A␤ 42 exposure, and the activation of autophagy increased pERK1/2 level and salvaged the disinhibition of hippocampal neurons. These data suggest that diminished GABAergic tone likely starts from the preclinical stage of AD, so some GABAergic stress test may be effective for identifying cognitively normal elder adults. Strategies against the dysfunction of autophagy should be adopted in the early stage of AD because of its initial effects.
INTRODUCTION
Alzheimer's disease (AD) is the most familiar form of dementia in the elderly, affecting about 35 million people in the world [1] . Although AD is one of the diseases requiring greatest healthcare and economic challenges globally, no effective therapy to halt or delay its progression has been developed [2] . It is acceptable that AD is a progressively neurodegenerative disorder of the brain, and eventually results in irreversible loss of intellectual abilities. Central to the pathogenesis of AD are selective loss of neurons, and the formation of senile plaques [preferentially composed of amyloid ␤-protein (A␤)] and neurofibrillary tangles), which are the major neuropathological hallmarks of AD [3] . Many neurodegenerative diseases are associated with the conformational change of a normal self-protein into toxic oligomeric species. As one of these proteins, A␤ is confirmed to play a causal role in the pathogenesis of AD [4] . Although the neurotoxicity of A␤ has attracted much attention, the detailed mechanisms remain to be elucidated.
Because A␤ typically starts to aggregate long before the occurrence of AD symptoms, specific strategy against A␤-mediated neurotoxicity may constitute a useful approach for AD treatment, perhaps as important as agents against A␤ aggregate formation [5] [6] [7] . In a recent research, Poljak et al. proposed that plasma A␤ measures can serve as biomarkers of AD because plasma A␤ levels have a close relationship with cognition and hippocampal volumes [8] . As a small protein, A␤ mainly includes two isoforms, soluble A␤ and insoluble A␤ [9, 10] . In the classic view, A␤ aggregation is confirmed to be the vital reason for the neurotoxicity [11] . Therefore, in this current study, we set up a cellular model with A␤ 42 oligomer and explored its detrimental effects on hippocampal neurons in the early stage. The discovery of A␤ 42 -induced initial actions will facilitate effective intervention against AD-related neurodegeneration.
Autophagy is one of the important cellular degradation modes for long-lived or damaged proteins and organelles [12] [13] [14] . To date, autophagy has been the apple of the researchers' eye, and dysfunctional autophagy is testified to be involved in many chronic proteinopathies, including Huntington's disease, amyotrophic lateral sclerosis, Parkinson's disease, AD, and so on [15] [16] [17] [18] . Although there are many paradoxical reports in the role of autophagy in AD, it is well acceptable that autophagic flux is changed significantly in AD models. The intervention of autophagy in AD models has been documented to ameliorate diverse pathological deficits, and improves synaptic and cognitive functions [19] [20] [21] . In addition, autophagy is considered to have close relationship with oxidative stress and endoplasmic reticulum stress, which are important pathological processes in AD [22] . However, although autophagy alterations are the important pathological phenomena, the autophagic stress-related mechanisms in AD neurons are not clear by now and require deep exploration.
In the brain, neuronal activities depend on the balance between excitatory and inhibitory neurotransmission. A loss of excitation/inhibition balance, as an example of depressed inhibition, will always lead to excessive excitation, and a cognitive dysfunction will occur [23] . Since the suppression of neuronal glutamate excitatory signaling has been regarded as a neurophysiologic mechanism toward cognitive impairment in AD [24] , proper inhibitory ␥-aminobutyric acid (GABA) signaling is crucial for the maintenance of normal neural circuit functions [25] . Decreased GABA-mediated currents combined with decreased mRNA and protein level of GABA receptor subunits were reported recently in AD [26] . In the current study, we argue that the GABAergic system is the onset avenue to the occurrence of AD. Overall, deficits in GABAergic system have not been addressed by current therapies, thereafter manipulation of the transmitter system may be a strategic potential of AD treatment and support the possible therapeutic one against AD by combining with repurposed medicine [3] .
METHODS

Hippocampal neurons culture and treatments
Pregnant Wistar rats were got from the animal facility of the Capital Medical University. All experimental animals were approved by the Institutional Animal Care and Use Committee (IACUC). Hippocampal neurons culture was performed as described previously [27] . Shortly, we anesthetized pregnant Wistar rats with pentobarbital, and the E18-19 embryos were sent by cesarean section. The hippocampi were taken out and incubated with 0.25% (w/v) Trypsin-EDTA (Gibco Inc., Grand island, NY, USA) for 15 min at 37 • C, then dissociated in a mechanical way. The resulting single cell suspension was attenuated to 1×10 5 cells/ml in high glucose Dulbecco's modified Eagle's medium (DMEM, Gibco) containing 10% (v/v) fetal bovine serum, 5% (v/v) equine serum and 2 mM L-glutamine, then located in 35 mm cell plates coated with poly-L-lysine (Gibco) (0.5 mg/ml). Cells were kept at 37 • C in a humidified incubator with 5% CO 2 . After approximately 4-6 h, the medium was changed with serum-free Neurobasal medium (Gibco) containing B 27 supplement (Gibco) and 0.5 mM cytosine arabinoside (Sigma-Aldrich Corp., St. Louis, MO, USA) to suppress the growth of glia cells. Thereafter, half of the media was substituted every 3-4 days and the neurons were ready for experiments on 10-14 days after plating.
Preparation of Aβ 42 peptides
The A␤ 42 peptides were prepared as we previously reported [28, 29] . Briefly, the peptides were dissolved to 1 mM in hexafluoroisopropanol (HFIP) and aliquoted in sterile microcentrifuge tubes. The HFIP was removed under vacuum in a Speed Vac, and the peptide film was stored dessicated at -20 • C. For the aggregation protocols, the peptide was first resuspended in dry dimethyl sulfoxide (DMSO) to a concentration of 5 mM. To maintain oligomeric conditions, Ham's F-12 (phenol red-free) was added to make the peptide at a final concentration of 100 M and incubated at 4 • C for 24 h. Soluble forms of oligomeric A␤ 42 peptides were got after the above procedures, which was confirmed with atomic force microscopy. Vehicle controls were designed by addition of the same volumes of DMSO used for the peptide preparations. For the A␤ incubation studies, freshly diluted oligomer A␤ 42 (2.5 M; American Peptide, Sunnyvale, CA) was added to the hippocampal cultures, and electrophysiological measurements were performed after 24 h.
Thiazolyl blue tetrazolium bromide (MTT) assay
Ten microliters of MTT (5 mg/mL stock in phosphate-buffered saline [PBS]) was allocated to each well (96-well plate, 100 l medium/well), and the neurons were incubated for 4 h. The blue formazan was dissolved with 100 L dimethyl sulfoxide (DMSO), and OD values of the mixture were achieved at 550 nm and 650 nm with a Bio-Rad microplate reader. All related MTT assays are not less than 4 separate samples, which were surveyed in triplicate. Survival of vehicle-treated control neurons not exposed to A␤ 42 was taken as 100%, and the data of other groups were given as a percentage of the control.
Lactate dehydrogenase (LDH) release assay
LDH release assay was achieved to indicate cell death by metering the quantity of LDH in the medium from injured cells because of necrosis and secondary necrosis from apoptosis or autophagic cell death. 25 L culture medium was gathered from different groups after A␤ 42 exposure. An equivalent volume of detection reagent (CytoTox One Reagent, Promega, Madison, WI) was allocated to each well containing the culture medium and kept for 30 min avoiding the light at room temperature (RT). Absorbance was got (wavelength: 490 nm) with a colorimetric microplate reader (SpectraMax Gemini, Molecular Devices). Six replicates for experimental conditions were measured and three such experiments were carried out.
JC10 staining
After A␤ 42 exposure, the medium was discarded and replaced with normal medium containing 25 M JC10 membrane potential-sensitive fluorescent dye. After 15 min of loading, red and green fluorescence images of the same field were visualized and gained with the Thermo Scientific ArrayScan XTI high content Reader (Thermo Scientific, USA). The red and green images were merged to present depolarization of depicted by loss of the red fluorescence of the merged images. Representative merged images from three independent experiments are shown.
Immunofluorescence staining
After A␤ 42 exposure, cells were fixed in 4% paraformaldehyde for 30 min at RT. Next, 4% paraformaldehyde was discarded and the neurons were rinsed with in PBS for 3 times, and permeabilized in PBS containing 0.2% Triton X-100 for 1 h at RT. The neurons were blocked (8% goat serum in PBS, 1 h, RT) and incubated overnight (4 • C) with primary antibodies: GABA (monoclonal mouse, 1 : 200; Thermo Scientific, Rockford, IL, USA), GAD-65 (polyclonal rabbit, 1 : 200; Abcam, Cambridge, MA, USA), PSD95 (polyclonal rabbit,1 : 200, Cell signal, USA), and synaptophysin (polyclonal rabbit,1 : 200, Cell signal, USA). After fully washing, the neurons were incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (1 : 500; Molecular Probes, Eugene, OR, USA) or Alexa Fluor 594-conjugated goat anti-mouse IgG (1 : 500; Molecular Probes, Eugene, OR, USA) for 2 h (RT). All samples were counter-stained by Hoechst 33258 (sigma; 1 : 5000; 10 min). Images were visualized and gained with the Thermo Scientific ArrayScan XTI high content Reader (Thermo Scientific, USA), confocal microscopy or fluorescent microscope imaging system (Leica, Germany).
Thermo Scientific ArrayScan XTI high content Reader (Thermo Scientific, USA) was used for taking the images and quantifying the fluorescent intensity automatically. Before the measurement, the specific regions of every well are selected, which will be taken as the standard regions in different wells. After that, the Reader focused on the hippocampal neurons dependent on their stained nuclei and supported the fluorescent intensity of different fluorescent channels automatically.
Transmission electron microscopy
After hippocampal neurons were cultured to 10-14 days, they were exposed to A␤ or A␤ and rapamycin. Then, they were scraped off, fixed (with 2.5% glutaraldehyde/2% formaldehyde), washed and stored at 4 • C until embedding. After that, the samples were post-fixed with 2% osmium tetroxide, dehydrated with cold graded ethanol (25%, 50%, 70%, 95%, and 100%) and rinsed in propylene oxide. Images were acquired with a Hitachi H-7500 electron microscope at 80 kV. For quantization of autophagosomes, the averaged data was obtained from at least 50 independent cells.
Whole-cell patch clamp recording
The whole-cell voltage-clamp technique was selected to record the post-synaptic currents. A PP-83 micropipette puller (Narishige, Japan) was used to pull the patch electrodes of thick-walled borosilicate glass (VWR Scientific, West Chester, PA). The patch-pipette solution includes (in mM): 140 KCl, 10 Hepes, 10 EGTA, 2 MgCl 2 , 2 Na 2 ATP, 1 CaCl 2 , pH 7.3. The required resistance of glass electrodes was 3-5 M with intracellular pipette solution. Before electrophysiological experiments, culture dishes were washed and covered with extracellular solution containing (in mM): 140 NaCl, 5 KCl, 1 MgCl 2 , 0.5 CaCl 2 , 10 Glucose, 10 HEPES, pH 7.4. Miniature excitatory post-synaptic currents (mEPSCs) were got with the existence of GABA A receptor antagonist bicuculline (50 M, Sigma), the AMPA receptor antagonist DNQX (20 M, Tocris) and TTX (1 M, Sigma) in the extracellular solution. mEPSCs were achieved for no less than 5 min at a holding potential of -70 mV from cultured hippocampal neurons without synaptic stimulation. Spontaneous miniature inhibitory post-synaptic currents (mIPSCs) were isolated by the addition of 20 M 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 50 M aminophosphonobutyrate (APV), antagonist to the excitatory ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methy-daspartate (NMDA) receptors, separately. Also, 1 M TTX was added to the extracellular solution. The currents of mIPSCs were completely blocked by 50 M bicuculline, the antagonist of the inhibitory GABA A receptor, proving that they were mediated by GABA A receptors. We chose recorded neurons according to their morphology and surrounding density. The standard is that they look similar to hippocampal pyramidal neurons. Relatively isolated or spherically shaped neurons were excluded. Data was acquired with an Axopatch 200B amplifier (Axon Instruments, Forster City, CA) and analyzed using pCLAMP 9.0 (Axon Instruments). Fast and slow capacitances were offset and series resistance was always made up (about 70%).
Sample preparation and western blot analysis
As reported previously [30] , cultured neurons were rinsed with 4 • C PBS rapidly and homogenized in Buffer C (50 mM Tris-Cl, pH 7.5, containing 2 mM EDTA, 1 mM EGTA, 100 mM iodoacetamide (SHgroup blocker, IAM), 5 g/ml each of leupeptin, aprotinin, pepstatin A and chymostatin, 50 mM potassium fluoride, 50 nM okadaic acid, 5 mM sodium pyrophosphate). The protein concentration was decided by using BCA kit (Pierce Company, Rockford, IL, USA). 25 g proteins of each sample were loaded with sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (10% (w/v) SDS gel). Then, proteins were electrophoresed and shifted onto poly-vinylidene difluoride (PVDF) membrane (GE Healthcare, UK) at 4 • C. After completely washed with TTBS (20 mM Tris-Cl, pH 7.5, 0.15 M NaCl and 0.05% Tween-20), the PVDF membrane with proteins was rinsed with 10% non-fat milk in TTBS (1 h, RT) and then incubated with the following incubation with anti-SQSTM1/p62 (Cell Signaling Technology (CST), anti-LC3 (Abcam Technology, Cambridge, MA, USA), anti-GABA (Abcam), anti-Synaptophysin (CST), anti-ERK1/2 (CST), anti-phospho-ERK1/2(CST) antibodies and the corresponding secondary antibodies. The Enhanced Chemiluminescence (ECL) kit (GE Healthcare, UK) was used to represent the signals. To guarantee equal loading of protein, the blots were reacted with primary monoclonal antibody against beta-actin (Sigma) or GAPDH (CST).
PD98059 (10 M, Sigma), Curcumin (10 M, Sigma), and Rapamycin (1 M, Sigma) were added to block ERK1/2, activate ERK1/2 or activate microautophagy (thereafter autophagy) respectively before A␤ 42 exposure. Quantitative analysis for immunoblotting was performed after scanning of the X-ray film with Quantitative-One software (Gel Doc 2000 imaging system, Bio-Rad Company, CA, USA).
Statistical analysis
Data are presented as mean ± S.E. Statistical analysis was performed by one-way analysis of variance, and followed by all pairwise multiple comparison procedures with Bonferroni test (sigmastate 10.0). p < 0.05 was confirmed statistically significant.
RESULTS
Aβ 42 decreases the inhibitory pre-synaptic efficiency in hippocampal neurons
We investigated whether A␤ 42 affected glutamate release in the hippocampal neurons by measuring the mEPSCs (Fig. 1A) . The sEPSCs contain action potential-dependent and action potentialindependent synaptic events (mEPSCs). To separate the mEPSC events, 1 M TTX was added to block the action potential-dependent glutamate release. There is no significant difference in the frequency and mean amplitude of mEPSCs between the control and A␤ 42 treatment groups (Fig. 1B , C, p > 0.05, n = 11). Then, mIPSCs were recorded with the whole-cell recording method (Fig. 1D) . A significant difference in the frequency of mIPSCs between the control and A␤-treatment group is observed (Fig. 1E , * p < 0.05, n = 10), suggesting less pre-synaptic release probability in GABAergic neurotransmitter systems after A␤ exposure. However, there was no significant difference in the mean amplitude of mIPSCs between the different experimental groups (Fig. 1F , p > 0.05, n = 10). Furthermore, the other post-synaptic properties of mEPSCs and mIPSCs, including rise time constant and decay time constant were analyzed with Clampfit 9.0 (Axon Instruments). There is no distinctive difference between the control and A␤ treatment groups (data not shown), the neurons were used in this experiment on 10-14 days after plating.
Based on the results, we draw a conclusion that inhibitory transmission is more susceptible to A␤ 42 . Provided that the modification in inhibitory transmission is the onset of AD, then the related synaptic mechanism should be clarified, which will support an effective early target against AD progression. Some evidence suggests that the activation level of ERK1/2 is associated with A␤ 42 -induced cytotoxicity [31] . In the current study, we explored the role of ERK1/2 in the inhibitory transmission. PD98059, the inhibitor of ERK1/2, was added into the medium, and the frequency of mIPSCs was reduced, suggesting that ERK1/2 may be involved in pre-synaptic inhibitory transmission. In the further study, we will investigate the interaction between A␤ 42 and ERK1/2 in the early onset of AD.
The number of GABAergic neurons and synapses does not contribute to Aβ 42 -induced disinhibition
Although we investigated the modification of mIPSCs, it still needs to clarify the impact of A␤ 42 on the number of GABAergic neurons and synapses. If the number is stable, then we will conclude that A␤ 42 at this concentration induces only functional remodeling of inhibitory transmission, or the structural remodeling one occurs. Provided that there is only functional modification caused by A␤ 42 , to our knowledge, the early alteration of inhibitory transmission is reversible.
First, we observed the number of GABAergic neurons ( Fig. 2A-C , the neurons were used in this experiment on 10-14 days after plating) in hippocampal neurons with immuno-fluorescence staining, and found that there was no difference between the different experimental groups. Second, whether or not the number of inhibitory synapses is changed should be considered. To clarify this number of inhibitory synapses, the cultured hippocampal neurons were stained with GABA and GAD65, which was decided a pre-synaptic marker of inhibitory synapses (Fig. 3A) . Because the density of cultured neurons is destined to affect the amount of synaptic proteins, the fluorescence of GABA is performed as a background control in this experiment. The fluorescent intensity of GAD65 was averaged by that of GABA. The results suggested that A␤ 42 did not influence the mean fluorescent intensity of GAD65 (Fig. 3B) . Then, the cultured hippocampal neurons were stained with GABA and PSD95, a post-synaptic marker (Fig. 3C) . Provided that 2.5 M A␤ 42 did not influence the excitatory transmission based on the previous results, the modification of PSD95 expression will tend to represent that of inhibitory transmission although PSD95 is not the specific postsynaptic marker for inhibitory synapses. There is no distinct difference between the different experimental There is no significant difference in the mean amplitude of mIPSCs between the different experimental groups (p > 0.05, n = 12). However, a significant difference in the frequency of mIPSCs between the control and A␤ 42 -treatment group is observed ( * p < 0.05, n = 12), suggesting less pre-synaptic release probability of inhibitory transmission. In addition, there is a significant difference in the frequency of mIPSCs between the control and PD98059 treatment groups, indicating ERK1/2 may be involved in the regulation of GABAergic transmitter release ( * p < 0.05, n = 10).
groups in the mean fluorescent intensity of PSD95 (Fig. 3D) . Since the stable expression of GAD65 and PSD95, we conclude that the number of synapses is stable after 2.5 M A␤ 42 exposure.
Based on these results, neither the number of GABAergic neurons nor that of the GABAergic synapses is changed by 2.5 M A␤ 42 exposure, but the frequency of mIPSC does change after the treatment, indicating that A␤ 42 only caused functional modification under this experimental condition of our study. Still, the detailed mechanism is not clear and needs to be clarified.
Aβ 42 did not distinctly injury cultured hippocampal neurons in the early stage
The neuronal loss is one of the hallmarks of AD, and A␤ 42 plays an important role in it. In order to exclude other possibilities that will influence neuronal electrical activities, such as viability and neuron conditions, we observed the viability with MTT and LDH assay, and mitochondrial membrane potential with JC10 staining. There is no significant difference between the different experimental groups in viability of the cultured neurons (Fig. 4A, B , p > 0.05, n = 6). Meanwhile, there is no distinct difference between the experimental groups in the intensities of JC10 after 2.5 M A␤ 42 exposure for 24 h, suggesting that mitochondrial membrane potentials were not modified (Fig. 4C , p > 0.05, n = 7). All these results suggest that 2.5 M A␤ 42 for 24 h is not the fatal condition for cultured neurons, although it may be detrimental to them. Based on that, there is no significant neuronal loss; we deduce that 2.5 M A␤ 42 may be corresponding to the stage of preclinical AD. 42 -involved disinhibition, which influenced the ERK cascade component, synaptophysin ERK1/2 signaling cascade is of great importance in transferring signals from growth factor receptors to control gene function and prevent apoptosis [32] . Emerging evidence has shown A␤ may have a role in multiple intracellular signaling pathways such as the MAPK signaling pathways [33] . Fitore Raka et al. found that A␤ 42 oligomer activated ERK1/2 via CaMKII and no distinct neurotoxicity was observed [34] . Nirut Suwanna et al. investigated A␤ 42 oligomer decreased phosphorylation of ERK1/2 and induced neurotoxicity. Although ERK1/2 is definitely involved in A␤ 42 -induced cascade, there are still some obscurities about it. First, the activation level of ERK1/2 influenced by A␤ 42 is inconsistent in different reports even under the same A␤ 42 concentration [35] [36] [37] . Second, although A␤ 42 is affirmed to be detrimental to neurons, it seems that the following modification of ERK1/2 does not always contribute to neurotoxicity. Based on our current results (Fig. 4A, B) and the previous reports, we consider that ERK1/2 is important in A␤ 42 -induced cascade for functional regulation but not the vital factor for neuronal viability.
ERK1/2 may be involved in Aβ
A␤ is reported to be closely associated with synaptic function modification and early synaptic loss in AD [38] . Combined with our current results, it is confirmed that pre-synaptic functions have been changed. So, the possible related pre-synaptic proteins were addressed with western blot assay.
Experimental results showed that the expression of synaptophysin was decreased significantly by A␤ 42 . Meanwhile, the expression of synaptotagmin, syntaxin, and synapsin are not significantly changed (data are not shown in this paper). Hsia et al. reported a distinct reduction of synaptophysin at excitatory pre-synaptic sites in an A␤PP transgenic mouse strain at 2-3 months of age, resulting in the dysfunction of excitatory transmission [39] . Although this phenomenon is also correlated with the increased level of A␤, the A␤PP transgenic mouse has rep- resented the symptoms of AD. Compared with our current results, dysfunction of pre-synaptic inhibitory transmission in the early stage and that of presynaptic excitatory transmission in the later stage may be all responsible for the cognitive impairment of AD, mainly resulting from transformed synaptic plasticity.
When curcumin, the activator of MEK (the upstream kinase of ERK1/2), was added into the medium, both the phosphorylation level of ERK1/2 and expression of synaptophysin were increased from the suppression by A␤ 42 (Fig. 5A-C) . Then, we conclude that A␤ 42 may exert its early effect via ERK1/2-synaptophysin pathway. In addition, the decreased frequency of mIPSCs is rescued by curcumin, which further proves the role of ERK1/2 in A␤ 42 -mediated pre-synaptic modification (Fig. 5D-F) . At the same time, phosphorylation levels of the other MAPK family members, p38 and JNK, were also detected, and there was no significant difference between the different experimental groups. Further, we observed the relationship between ERK1/2 and synaptophysin with co-IP assay and confirmed their interaction (Fig. 6A) . Provided that only synaptic functions are modified but no neurotoxicity phenomenon occurs under our experimental conditions, we propose that ERK1/2-synaptophysin-involved disinhibition may be the biomarker for early AD. A) Representative results of the expression of GABA with western blot assay. B, C) Quantitative analysis shows A␤ reduces the phosphorylation of ERK1/2 and expression of synaptophysin, which will be reversed by the Curcumin, an activator of MEK (p < 0.05, n = 6). D) Representative results of mIPSCs in different experimental groups. E, F) Quantitative analysis shows the mean amplitude and frequency of mIPSCs in the control, naïve A␤ treatment and Curcumin+ A␤ groups. There is no significant difference in the mean amplitude of mIPSCs between the different experimental groups (p > 0.05, n = 7). A significant difference in the frequency of mIPSCs between the control and A␤ treatment group is observed and can be rescued by Curcumin treatment (*p < 0.05, n = 8), which indicates that ERK1/2 dephosphorylation contributes to A␤-disinhibition in the hippocampal neurons. 
Aβ 42 decreased the autophagy level of cultured hippocampal neurons, which had a role in the de-phosphorylation of ERK1/2
To address the influence of A␤ 42 on autophagy, we observed the LC3II/LC3I ratio and the expression level of SQSTM1 with western blot assay (Fig. 6B) . Immunoblotting of cell lysate with A␤ 42 -exposure was detected using the anti-LC3 antibody that addressed both LC3I and LC3II. A␤ 42 -exposure significantly decreased LC3II levels or the ratio of LC3II/LC3I (Fig. 6B, E) . SQSTM1/p62, which is specifically degraded by autophagy via binding to LC3, is considered as accepted markers for autophagy [40] . The expression level of SQSTM1 is increased by A␤ 42 -exposure too, which further confirmed that autophagy influx was impaired by A␤ 42 (Fig. 6B,  C) . Since we revealed both ERK1/2 and autophagy were involved in A␤ 42 -induced neuronal dysfunction, our concern was transferred to the correlation between them. Strikingly, when the activator of autophagy, rapamycin, was added into the medium, the decreased tendency of p-ERK1/2 was reversed (Fig. 6B, D) .
By now, there are some conflicting reports on the relationship between AD and autophagy, which may result from the different modifications in autophagy corresponding to different AD stage. Nevertheless, in this study we confirm suppression of autophagy may contribute to AD in the early stage. Since we have concluded that there is a correlation between ERK1/2 and autophagy, it still needs to be clarified whether autophagy-ERK1/2 is involved in the expression of synaptophysin after A␤ 42 exposure. Immunofluorescence staining method was performed and the experimental results revealed A␤ 42 reduced the expression of synaptophysin, which may be salvaged by either rapamycin or curcumin (Fig. 7A, B) . Combined with the previous results, it can be concluded that A␤ 42 -induced suppression of either ERK1/2 or autophagy contributes to the decrease of synaptophysin. 
The salvage of autophagic dysfunction alleviates Aβ 42 -induced disinhibition in cultured hippocampal neurons
In the previous results, the suppression of autophagy by A␤ 42 was investigated and confirmed as the upstream of ERK1/2-synaptophysin. To further explore the relationship between autophagy and disinhibition, rapamycin was added after A␤ 42 exposure, which increased the autophagy significantly (Fig.8A) . Then, we explored the influence of reversed autophagy on mIPSCs and found that increased autophagy alleviated A␤ 42 -induced disinhibition of hippocampal neurons (Fig. 8B-D) . Moreover, when 3-MA (a specific inhibitor of autophagy) was added in the medium, disinhibition of hippocampal neurons occurred (data not shown), suggesting there may be a close relationship between the autophagic level 42 decreases cell viability of cultured hippocampal neurons significantly ( * p < 0.05 versus that of control, n = 6 per group), which is salvaged by curcumin or rapamycin respectively ( # p<0.05 versus that of A␤ treatment group, n = 6 per group). F) Quantitative analysis of LDH release shows that 50 M A␤ 42 increases LDH release ( * p < 0.05 versus that of control, n = 6 per group), which is reversed by curcumin or rapamycin, respectively ( # p < 0.05 versus that of A␤ treatment group, n = 6 per group). and inhibitory synaptic transmission even under the physiological conditions. In further exploration, this phenomenon deserves a thorough observation. From these results, we draw a conclusion that autophagy is important for the maintenance of GABAergic functions at the synaptic sites, and the disinhibition is reversible in the early stage. Since we find that disinhibition of the neurons is the initial step of A␤ 42 induced neurotoxicity, the strategies on autophagic dysfunction may be promising for AD treatment in the future.
In addition, we explored the relationship between synaptotoxicity and neurotoxicity induced by A␤ 42 . After rapamycin and curcumin were added into the medium, respectively, the hippocampal neurons were exposed to 50 M A␤ 42 for 2 h. Thereafter, viability and LDH release were observed with MTT and LDH assay. 50 M A␤ 42 decreased the viability of hippocampal neurons, which was alleviated by rapamycin or curcumin pretreatment (Fig. 8E, F) . Since synaptotoxicity by A␤ 42 was via depressed ERK1/2 and autophagic signaling pathway, synaptotoxicity might be the vital initiation of neurotoxicity, which shed light on the treatment for preclinical AD. However, although synaptotoxicity may be the necessary "prelude" to neurotoxicity, the corresponding "passage" is still required to be discovered in the future (Fig. 9) . Due to the current results, we propose that synaptotoxicity may occur chronologically before neurotoxicity, supporting an early therapeutic target for AD.
DISCUSSION
From the present study, we draw the following conclusions: 1) In the early stage, A␤ 42 disinhibited hippocampal neurons before its influence on the excitatory transmission; 2) A␤ 42 disinhibited hippocampal neurons through autophagy-ERK1/2-synaptophysin pathway; 3) Autophagy may be involved in the maintenance of GABAergic synaptic plasticity; and 4) Synaptotoxicity occurs before neurotoxicity under A␤ 42 exposure. Based on these results, it will be an effective therapeutic method to increase neural inhibition by increasing inhibitory transmission, which may prevent neuronal depolarization and the following activation of NMDARs [24] . Our current study firstly reports decreased activity of autophagy-ERK1/2-synaptophysin signaling pathway contributing to A␤ 42 -induced synaptotoxicty and provides a favorable pharmacological profile for clinical treatment of AD in early stage.
Synapses are the basic structures for memory and cognition, which represents synaptic plasticity that in turn modulates neurotransmitter release from the pre-synaptic sites, and the number, types, and properties of neurotransmitter receptors at the post-synaptic sites [41] . The mature brain has a remarkable structural and functional plasticity; however, some interventions may injury its plasticity after the developmental window is closed [42] . The balance between glutamatergic (excitatory) and GABAergic (inhibitory) neurotransmitter systems is of great importance to CNS physiological homeostasis. It has been reported that epileptic activity may be more common in the late-onset of 'sporadic' AD than was estimated previously [43] , which indicates a misbalance between glutamatergic and GABAergic neurotransmitter systems in AD. In the late stage of the AD brain, extensive neuronal and synaptic loss is found in areas of the brain essential for cognition and memory [3] . These discoveries are summed up into the synaptic failure hypothesis indicating that "AD represents, at least initially, an attack on synapses" [44, 45] . Overall, the early-onset modifications and the related mechanism on synapses of AD models need to be explored further, which may give directions for the early treatment of AD. To get proper candidate therapeutic treatments, it is essential to recognize the type, extent, and onset of pathologies in each AD model, including in vivo and in vitro ones.
In previous studies, the relationship between excitatory transmission and AD has been elucidated. Intermediate levels of A␤ enhance pre-synaptic activity by activation of synaptic NMDARs and AMPARs, whereas abnormally high or low levels of A␤ impair synaptic activity by activation of peri-synaptic NMDARs, mGluRs, and ␣7-nAChRs, which results in the postsynaptic depression or reduced pre-synaptic efficiency, respectively [46] . Inhibitory neurotransmission in the brain is largely mediated by GABA, including GABA A receptors and GABA B receptors. The balance of inhibitory and excitatory transmission is of great importance in the regulation of all aspects of brain function, since both of them are critical for maintaining the proper balance of activity in the brain. Loss of the balance between excitatory and inhibitory transmission resulting from dysregulation of GABAergic signaling pathway may lead to AD-related cognitive impairments [26, 47] . Network hyperexcitability may lead to changes in intrinsic membrane properties as well as synaptic and connectivity defects, which have all been described in AD models [48] . It has been reported that GABA decreased significantly in lumbar cerebrospinal fluid in AD patients, suggesting GABAergic system is closely related to AD [49] . In the current study, A␤ induced the disinhibition of the hippocampal neurons in pre-clinical stage, which will lead to respective hyperexcitability.
By now, there are some paradoxical results about AD-related changes in the inhibitory transmission. Schmidt et al. found that age-related decline of functional inhibition in rat cortex [50] , whereas Leubke et al. found the increment of inhibitory postsynaptic activities [51] , which was also caused by aging. Wu et al. reported that a high GABA content both in reactive astrocytes of the dentate gyrus of a mouse model for AD (5xFAD) and in dentate astrocytes of human AD patient brains [52] . Thereafter, increased tonic inhibition and memory deficit occurred [53] . While, Ulrich proposed that A␤ induced the downregulation of GABA A receptors via inhibiting their internalization [54] . Thus, therapeutic strategy targeting GABA synthesis or release may act as a new star against AD. In the present study, we found A␤ 42 (2.5 M) disinhibited hippocampal neurons before its influence on the excitatory transmission system, indicating that GABAergic neurons may be more susceptible to synaptic damage in AD brains. The differential effects of A␤ 42 on excitatory and inhibitory synapses may bring imbalances in circuit and network activity. The GABAergic dysfunction caused by A␤ 42 may contribute to the development of aberrant synchrony in neural networks and disruption of cogni-tive functions [46, 55] . In addition, combined previous studies with our results, increased GABA in the reactive astrocytes may initially be part of a compensatory mechanism to the disinhibition in neurons of AD early stage.
The effects of A␤ 42 seem to be in a dose-dependent way, which is documented in many studies. A␤ 42 in the micromolar range can result in cellular injuries, which has been observed in many studies [56] . Benilova et al. found only certain synthetic and cellderived A␤ preparations are synaptotoxic at pertinent low nanomolar concentrations in vitro [57] . Puzzo et al. have reported A␤ in the picomolar range positively modulates synaptic plasticity and memory in hippocampus [58] . Although most researchers have considered A␤ as just a "garbage" product of A␤PP metabolism, it is found that picomolar levels of A␤ 40 play a neurotrophic role in cell cultures [59, 60] . From our study, A␤ 42 in micromolar range acts differently from that in nanomolar and picomolar, which may reflect the injury stage and should be considered as the treatment of AD. While, the A␤ oligomer level used in the different experiments is significantly different from each other even in micromolar range. The proper concentration depends on the source of A␤ oligomer, the used experimental cells, and the exposure duration [61] [62] [63] [64] . So, in our opinion, it may be necessary to explore the proper concentration of the A␤ oligomer based on the experimental requirement before the formal experiment. Although we cannot decide if 2.5 M A␤ 42 is actually corresponding to which stage of AD, low-concentration A␤ 42 may mimic its early stage.
Autophagy and apoptosis play pivotal roles in the maintenance of cellular homeostasis. The fate of autophagy is multifarious. It is now widely regarded as not only a vital homeostatic mechanism in healthy neurons as described in previous paragraphs but a cyto-protective response when further induced in chronic neurodegenerative disorders [65] [66] [67] . Recently, there has been a resurgence of interest in the relationship between AD and autophagy. It is reported that autophagy deficiency significantly reduced extracellular A␤ plaque burden. This reduction of A␤ plaque load was due to inhibition of A␤ secretion, which resulted in aberrant intra-neuronal A␤ accumulation in the peri-nuclear region [68] . In addition, autophagy is definitely a twoedged sword in AD pathologic process. Nilsson et al. reported impaired autophagic influx increased the level of intracellular A␤ in A␤PP-transgenic mice, and reduced extracellular deposits of A␤, indicating that autophagy-stimulating compounds resulted in both reducing toxic intracellular A␤ levels and exacerbating secretion of extracellular A␤ over time [69] . Nevertheless, Lipinski et al. reported upregulation of autophagy resulted from A␤-mediated reactive oxygen species production in AD patient [70] . Shin et al. reported that enhanced autophagy exerted a neuroprotective effect through modulation of A␤ clearance in AD models both in vitro and in vivo [71] . These conflicting data may be caused by the selection of different experimental conditions. But the common contribution of them was the clarification of the key role of autophagy in AD, which may be the target for the treatment of AD.
Multiple signaling pathways, including ERK1/2, have been shown to regulate expression of autophagy and lysosomal genes [72] . Martinez-Lopez et al. reported growth factor exposure increased the interaction of ERK cascade components with ATG proteins in the cytosol and nucleus [73] . In this study, it is found that the inhibition of autophagy would decrease the phosphorylation of ERK1/2 at the pre-synaptic site, indicating the dysfunction of autophagy is the primary step involved in A␤ 42 induced synaptotoxicity rather than just a secondary pathological consequence of cellular dysfunction. Casar and colleagues reported that there was a close interaction between LC3-II and the protein in ERK-scaffold complexes [74] . That is, the lack of LC3-II-positive structures after A␤ 42 exposure may result in the reduction of the scaffolds or cellular signaling platforms for facilitating ERK1/2 phosphorylation. Combined with our results, the suppressed autophagy by A␤ 42 may fail to supply effective scaffolds for the activation of ERK1/2 and result in the dysfunction of the cascade signals.
To date, some papers represent autophagy is involved in the regulation of synaptic plasticity. Shen et al. found autophagy promoted synapse development in Drosophila [75] . They discovered that a basal level of autophagy was required to positively regulate the development of neuromuscular junction and, remarkably did so by controlling highwire levels. Torres and colleagues reported autophagy played multiple roles in the pre-synaptic function of dopaminergic terminals in the striatum, involving in the turnover and degradation of synaptic vesicles, regulation of terminal volume and the kinetics of transmitter release [76] . In addition, it was investigated that KCl depolarization induced NMDAR-dependent autophagy through the inhibition of PI3K-Akt-mTOR pathway, indicating autophagy as a contributor to NMDAR-dependent synaptic plasticity and brain functions, then resulted in AMPAR degradation [77] . Further, the underlying mechanism of autophagic impairment at synaptic sites was explored. Tammineni et al. addressed that defective retrograde transport leads to autophagic impairment in AD axons and pre-synaptic terminals, which can be salvaged by promoting retrograde transport of autophagic vacuoles [78] . In the current study, autophagy is suppressed by A␤ 42 exposure, resulting in the deactivation of ERK1/2, and as a consequence, GABA synaptic transmission efficiency is disturbed. Our results supported a new line of evidence that autophagy is not just a pathological consequence but a vital initial for the regulation of synaptic functions. Strikingly, interventions on the autophagic dysfunctions have been found effective in the AD model mice [79] , providing a promising therapy target against AD on autophagic dysfunction.
Intraneuronal A␤ accumulation has been reported to induce a lot of structural and functional synaptic alterations, such as decreased expression of pre-synaptic proteins [80] . Synapsin I, synaptophysin, syntaxin, and microtubule-associated protein 2 (MAP2), and so on, have been addressed to decrease in AD or after A␤ 42 exposure [81, 82] . At odds with these data that we propose synaptophysin may be a new bio-marker for asymptomatic AD because synaptophysin only decreases specifically in our current study. Also, ERK1/2 is considered the upstream protein kinase of synaptophysin. Based on different experimental conditions, the different results are expected. However, all these collected data provide evidence that ERK1/2-synaptophysin pathway is vital in A␤ 42 -induced synaptotoxicty and should be laid adequate emphasis on.
